<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000639916"><TermName>triple-negative breast cancer</TermName><TermPronunciation>(TRIH-pul-NEH-guh-tiv brest KAN-ser)</TermPronunciation><TermDefinition><DefinitionText>Describes breast cancer cells that do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein. Also called ER-negative PR-negative HER2/neu-negative breast cancer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><TermDefinition><DefinitionText>Triple-negative breast cancer is defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). Also called ER-negative PR-negative HER2/neu-negative breast cancer.</DefinitionText><Dictionary>Genetics</Dictionary><Audience>Health professional</Audience></TermDefinition><MediaLink ref="CDR0000722901" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;triple-negative breast cancer&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722902" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;cáncer de mama triple negativo&quot;" language="es" id="_4"/><SpanishTermName>cáncer de mama triple negativo</SpanishTermName><SpanishTermDefinition><DefinitionText>Describe las células de cáncer de mama que no tienen receptores de estrógeno, receptores de progesterona o grandes cantidades de la proteína  HER2/neu. También se llama cáncer de mama RE negativo, RP negativo, HER2/neu negativo.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-07-02</DateFirstPublished></GlossaryTerm>
